investing in uk plc a summary of the economic contribution astrazeneca to and its regions an independent impact study by regeneris consulting t1124 nov 06 b 02 is leader global pharmaceuticals industry it researches develops manufactures sells medicines combat serious diseases conditions ranging from cancer schizophrenia operates across world ethically responsibly improving patients lives delivering employment wealth innovation knowledge one hubs worldwide operations where maintains corporate headquarters two largest r&d centres second manufacturing site numerous other facilities business support functions at glance a71 pioneering innovative new creating around working contributing economy competitive advantage for employing 64 000 people sourcing 590m goods services 11 8bn sales providing 2bn supportimg 38 jobs spending 750m on supporting 2 5bn gva gross value
